Jazz Pharmaceuticals to Host March Fireside Chats, Q4 EPS $6.62 on $1.18B Revenue
Jazz Pharmaceuticals will present fireside chats at the TD Cowen Health Care Conference on March 3 and the Barclays Global Healthcare Conference on March 12, with webcasts available on its investor site. Street forecasts call for Q4 EPS of $6.62 (up 0.3%) on $1.18 billion revenue and a +7.9% Earnings ESP.
1. Upcoming Investor Conferences
Jazz Pharmaceuticals will participate in two major investor events in early March: a fireside chat at the TD Cowen 46th Annual Health Care Conference on March 3 at 7:30 a.m. PT and another at the Barclays 28th Annual Global Healthcare Conference on March 12 at 7:00 a.m. PT. Both sessions will be webcast live and archived for 30 days on the company’s investor website.
2. Q4 Earnings Preview and Outlook
Analysts forecast Q4 EPS of $6.62, a 0.3% year-over-year increase, on revenues of $1.18 billion (up 8.4%). The company’s Earnings ESP of +7.9% combined with a Zacks Rank #3 suggests a likely EPS beat, supported by a +41.6% surprise in the prior quarter and two beats in the last four reports. The results are scheduled for release on February 24.